Please provide your email address to receive an email when new articles are posted on . Once-monthly fitusiran prophylaxis improved outcomes compared with on-demand treatment for patients with severe ...

This is a video synopsis/summary of an Insights involving Allison Wheeler, MD. Wheeler addresses the nuanced considerations for implementing prophylaxis in patients with mild to moderate hemophilia A, ...

ORLADEYO is now the first and only targeted oral prophylactic therapy for patients with HAE aged 2 and above. A capsule ...

New FRONTIER5 results show a direct switch to investigational Mim8 (denecimig) prophylaxis treatment from emicizumab, without the need for a washout period, was well-tolerated in adults and ...

Patients who received prophylactic concizumab had a mean overall annualized bleeding rate of zero compared with 9.8 among those who did not receive prophylactic therapy. 63.6% of patients in the ...

A recent follow-up to a 2007 study examined trends in prophylaxis treatment of hemarthrosis in a pediatric population with moderate-to-severe hemophilia A. Discharge codes were used to track bleeding ...

GVHD is the main procedure-related complication in allogeneic haematopoietic SCT, and the successful prevention and management of this complication is crucial for an optimal outcome. GVHD can be quite ...

Dr. Nigel Key and Dr. Anna Falanga join us for a conversation on the updated ASCO VTE prophylaxis and treatment in patients with cancer guideline. They discuss recent evidence assessing apixaban for ...

Hospitalization is often associated with acute physical and psychological distress. This is due to not only to the illness per se that precipitated the hospitalization, but also to hospitalization ...

ORLADEYO now first and only targeted oral prophylactic therapy for patients with HAE aged 2 and older – -Oral pellet formulation provides ...